Caliciviruses - Porcine Sapovirus
LEVELS: Highly unlikely; Mild; Already in the herd; No validated assay; Minor; Negligible; Little; Available, or not needed
| Register id | porcine_sapovirus |
| Type | virus |
| Scientific name | Porcine sapovirus |
| NCBI taxid | 1454551 |
| Evidence | 3 document(s) |
| Assigned | 2026-09-06, against criteria version 093366e352a2 |
Overview
Porcine sapoviruses are caliciviruses that are endemic in pig populations worldwide — RNA is found in 8-67% of pigs and on 7-88% of farms — and pigs are infected early in life. Unlike the porcine noroviruses, these do demonstrably cause disease: experimentally inoculated pigs all became infected and developed anorexia and diarrhoea, mild to severe, beginning two to four days after exposure and lasting three to seven days, and one natural farm outbreak of diarrhoea has been attributed to a sapovirus after the usual enteric pathogens were excluded. No mortality is described. The viruses are stable in the environment and relatively resistant to disinfection, so elimination from a herd is not a realistic goal; sows almost certainly pass protective antibody in colostrum and milk that limits damage in nursing piglets, and oral rehydration is likely to be effective treatment. Diagnosis is a research undertaking — the prototype strain could only be grown in culture when intestinal contents, later identified as bile acids, were added to the medium, and the sensitivity of the molecular assays has not been fully evaluated. There is no vaccine. Human and porcine sapoviruses fall into different genogroups, and there is no evidence of a direct threat to human health.
C1 Zoonotic potential
Likelihood of transmission from pigs to humans
Highly unlikely: Human infection with the agent has never been reported, or has been reported but is not attributed to pig or pork exposure
Basis. ch26 26.3.3.2, the entry's own Public Health section, in full: "Public health concerns over potential cross-species transmission and animal reservoir for sapovirus have been raised. HOWEVER, THERE IS NO EVIDENCE FOR THE DIRECT THREAT of porcine sapoviruses to human health." 26.3.1 says the same for the enteric caliciviruses as a group: "Based on limited data, there is no clear evidence that known porcine caliciviruses pose a threat to human health." The genetic basis for the concern, from 26.3.3.1: human sapoviruses belong to genogroups GI, GII, GIV and GV, porcine sapoviruses to GIII and GV-GXI, so THE TWO SHARE GENOGROUP GV; and "GVIII IS GENETICALLY MORE CLOSELY RELATED TO HUMAN SAPOVIRUSES (especially those of GV and GI) THAN TO OTHER SAPOVIRUS GENOGROUPS IN SWINE". Sapoviruses have been found in pigs, humans, chimpanzees, sea lions, mink, dogs, hyenas, lions, foxes, bats, rats and wild boar, and "it has NOT BEEN ESTABLISHED whether porcine sapoviruses are species specific." shic_2021_psav: "Some porcine and human SaVs are genetically similar. However, there is no documented transmission between pigs and people."
How this level was decided
MOVED L2 -> L1, re-read 2026-09-04 AGAINST THE REWORDED LABELS. ch26 26.3.3.2: "THERE IS NO EVIDENCE FOR THE DIRECT THREAT of porcine sapoviruses to human health." No human case has ever been attributed to a porcine sapovirus.
PREVIOUS ANSWER, kept because the evidence behind it has not changed, only the level boundary: Level 2, on the same reasoning as porcine norovirus and with a slightly different genetic argument. The plausibility is real and specific: pigs and people share genogroup GV outright, and one porcine genogroup is closer to the human viruses than to the other porcine ones, which is what a host jump looks like in retrospect. Species specificity has not been established either way. Against that, no human case has ever been attributed to a porcine sapovirus, and the chapter says so in a section written to answer the question. Plausible but never reported, with no control point implemented -- the level 2 label. Level 1 confirmed by direct statement.
C2 Zoonotic impact
Severity of human illness caused by the agent
Mild: Human illness is usually mild and self-limiting, and serious disease occurs only rarely
Basis. ch26 26.3.1: caliciviruses have a "recognized role in sporadic and epidemic ACUTE GASTROENTERITIS in humans". 26.3.3.2: "there is no evidence for the direct threat of porcine sapoviruses to human health." No human case attributable to a pig is described. shic_2021_psav: "Human caliciviruses (including noroviruses and sapoviruses) are a leading cause of food- and water-borne gastroenteritis worldwide." "Some porcine and human SaVs are genetically similar."
How this level was decided
Level 2, grading the illness that would follow if the route C1 calls plausible were taken. Human sapovirus disease is acute gastroenteritis -- the same clinical picture as norovirus, generally milder, self-limiting over a few days, and serious mainly in infants and the elderly. That is the level 2 label, and it is set level with porcine_norovirus for the same reason. Level 2 held, on the reading Eric set for porcine reovirus -- where the agent is a group and the family plainly sickens people, hedge upward. Human sapoviruses are a leading cause of gastroenteritis worldwide and the illness they cause is self-limiting gastroenteritis, which is level 2 rather than higher.
C3 Herd introduction risk
Effort required to keep the agent out of the herd
Already in the herd: Present in most herds, or carried by pigs themselves, so there is no introduction event to prevent
Basis. ch26 26.3.3.3: "Porcine sapovirus RNA has been identified FREQUENTLY in pigs (8-67%) AND PIG FARMS (7-88%) by RT-PCR in several countries", the United States among them, and "the geographical distribution indicates the WORLDWIDE OCCURRENCE AND ENDEMIC CIRCULATION of porcine sapoviruses among pigs and in pig farms. PIGS ARE INFECTED WITH PORCINE SAPOVIRUS EARLY IN LIFE." "At least 83% OF 30 SOW SERUM SAMPLES FROM OHIO PIG HERDS with PEC-associated postweaning diarrhea had antibodies reactive to PEC/Cowden." "In general, sapoviruses are characterized by STABILITY IN THE ENVIRONMENT and relative resistance to inactivation." 26.3.3.9: "it is likely that these viruses persist in the environment and IT MAY BE IMPOSSIBLE TO ELIMINATE THE INFECTION FROM PIG HERDS AND PREVENT NATURAL INFECTION OF PIGLETS." The second document in the folder shows the same thing prospectively: degroof_2025 followed clinically healthy pigs on commercial Dutch farms and found porcine sapovirus already present just before weaning, PEAKING ONE WEEK AFTER WEANING, with "the timing and magnitude of subclinical enteric virus infections across farms REMARKABLY SIMILAR". shic_2021_psav: "PSaV is most likely endemic in pigs worldwide." "Caliciviruses are stable in the environment, surviving at high temperatures and in acidic conditions." "The virus persists in the environment, making cleaning and disinfection critical."
How this level was decided
Level 1. Up to 88% of farms carry it, 83% of Ohio sows have antibody, pigs meet it in the first weeks of life, and the 2025 Dutch cohort found it arriving on schedule on every farm studied in clinically healthy pigs. There is no introduction event to prevent, and the chapter adds that elimination from a herd is probably impossible. The point the 2025 paper adds beyond prevalence is the CONSISTENCY -- the timing was remarkably similar across farms, which is what an agent that is simply part of the weaning transition looks like, rather than one that arrives from somewhere. Level 1 confirmed.
C4 Detection difficulty
Difficulty of recognizing and confirming infection
No validated assay: No pathogen-specific test of known reliability exists anywhere, and identification depends on sequencing or on primers that have not been critically evaluated
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c4l4, straightforward rating, published work but not widespread use of test method so not generally validated"
Basis. ch26 26.3.3.7, the whole Diagnosis subsection: "Porcine sapoviruses have been detected using electron microscopy, RT-PCR, and real-time RT-PCR. HOWEVER, THE SENSITIVITY OF MOLECULAR TESTS FOR LABORATORY DIAGNOSIS OF PORCINE SAPOVIRUS INFECTIONS HAS NOT BEEN FULLY EVALUATED. Antigen and antibody ELISAs were developed and used to study PEC/Cowden" -- that is, for one prototype strain in research. 26.3.3.1: the prototype was cultured only in primary porcine kidney cells "BUT ONLY BY INCLUSION OF INTESTINAL CONTENTS IN THE CULTURE MEDIUM", bile acids later being identified as the necessary factor. The nearest thing to a working assay is in the second folder document: degroof_2025 designed a porcine sapovirus RT-qPCR specifically for that study, alongside nanopore sequencing. shic_2021_psav: "The Cowden strain (PSaV-C) is the only cultivatable SaV." "Reverse transcriptase polymerase chain reaction (RT-PCR) assays have been described, including several that detect multiple enteric pathogens of swine." "Enzyme linked immunosorbent assays (ELISAs) have been developed to detect both PSaV antigen and anti-PSaV antibodies." "Based on VP1 sequencing, there are currently 19 genogroups and at least 52 genotypes... Genetic recombination within and between genogroups is known to occur."
How this level was decided
Level 4, and this entry is the framework's worked example at that level alongside porcine norovirus. Under the 2026-08-29 rewording the axis is whether a VALIDATED assay exists, and the chapter says the sensitivity of the molecular tests has not been fully evaluated -- a published primer set is not a validated assay. The 2025 paper is the closest anything comes and it cuts the same way: a research group designing its own qPCR for its own study is exactly the situation the C4 rework was written about. FLAGGED AS A LEVEL 3 OR 4 JUDGMENT for one reason: sapovirus is better characterised than its neighbours in this chapter -- it has a cultivable prototype, antigen and antibody ELISAs, and working qPCRs -- so if the view is that a reference laboratory could give a trustworthy answer today, this is level 3. The pass keeps it at level 4 to stay level with the framework's own example. LEVEL 4 HELD, AND FLAGGED. Against the level: PSaV appears in multi-pathogen enteric RT-PCR panels, which is exactly the shape of a routinely available diagnostic, and both antigen and antibody ELISAs exist. For the level: 19 genogroups, 52 genotypes and recombination between them is a moving target of the kind the 2026-08-29 rework put at 4, and only one strain of the whole genus is cultivatable. The enteric panel point is the strongest single argument for 3 in this batch.
C5 Production cost
Financial impact on the infected farm's cost of production
Minor: Small and generally short-lived losses with little effect on overall cost of production
Basis. ch26 26.3.3.5: "PORCINE SAPOVIRUSES ARE ONE OF THE VIRAL AGENTS THAT CAUSE DIARRHEA IN SWINE. With PEC/Cowden, the incubation period ranged from 2 to 4 days after oral inoculation, and clinical signs of ANOREXIA AND DIARRHEA PERSISTED FOR 3-7 DAYS... ALL INOCULATED PIGS BECAME INFECTED and developed clinical signs ranging from MILD TO SEVERE DIARRHEA." 26.3.3.4 gives the one natural outbreak: "natural infection of pigs with a porcine sapovirus GIII was reported on a farm where pig diarrhea was observed and OTHER COMMON ENTERIC VIRAL PATHOGENS (e.g. porcine epidemic diarrhea virus, porcine deltacoronavirus, transmissible gastroenteritis virus, porcine rotaviruses A, B, and C) WERE NOT DETECTED by PCR. Moderate segmental villous blunting, atrophy, and contraction were observed", confirmed in situ as sapovirus. Lesions are "indistinguishable from those produced by other enteric viral pathogens". Against that, degroof_2025 found sapovirus peaking one week after weaning in CLINICALLY HEALTHY pigs across commercial farms. No mortality figure and no cost figure appears. shic_2021_psav: "Infection with PSaV is often subclinical. Clinical illness occurs most frequently during the post-weaning period. Diarrhea can be mild to severe but is usually self-limiting." "Only a few outbreaks of diarrhea have been solely attributed to PSaV, including one in China (2008) and one in Iowa (2019)." "prevalence in feces from clinically ill and healthy pigs is often similar."
How this level was decided
Level 2, and the distinction from porcine norovirus at level 1 is deliberate and rests on two pieces of evidence the norovirus entry does not have. Sapovirus has a documented natural outbreak in which every other enteric virus was excluded by PCR and the lesions were shown in situ to be caused by this one, and it has an experimental infection in which all inoculated pigs developed clinical signs. So this agent does cause disease in the field, which puts it above level 1. It stays at level 2 rather than level 3 because the diarrhoea runs three to seven days and resolves, no death is described, and the 2025 cohort shows the virus passing through clinically healthy pigs on ordinary farms as a matter of routine. Small and generally short-lived losses. Level 2 confirmed. A US outbreak solely attributed to PSaV in Iowa in 2019 is a real event, but the diarrhoea is usually self-limiting and prevalence is similar in sick and healthy pigs -- short-lived losses.
C6 Market impact
Duration of material disruption to pork and pig markets
Negligible: Little or no material disruption to supply or demand when disease occurs on one or more farms
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c6l1, appears to be widespread and with little evidence of significant clinical signs, no reason to think market would react"
Basis. An endemic enteric virus of worldwide distribution, present on up to 88% of farms, with no trade measure, movement control or consumer response recorded anywhere in chapter 26. shic_2021_psav: "PSaV is not an OIE-listed disease. There are no restrictions for importation."
How this level was decided
INFERRED. Under the standing note SCORING/market_impact, an agent already endemic in US pigs and diagnosed without any market move on record is level 1. Level 1 confirmed.
C7 Treatment potential
Potential for treatment to improve outcomes
Little: Effective pathogen-directed treatment is available and works, or animals recover acceptably without it
CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.
Confirmed by Eric. CONFIRMED. "c7l1, no clinical or market imperative to develop a treatment"
Basis. ch26 26.3.3.9: "TREATMENT WITH ORAL REHYDRATION FLUIDS IS LIKELY TO BE SUCCESSFUL", and sows are likely to pass maternal antibody in colostrum and milk "and thus limit infection and damage in the gut of nursing piglets". 26.3.3.5: clinical signs "persisted for 3-7 days", and no mortality is described. No antiviral exists. shic_2021_psav: "There is no treatment for PSaV infection. In severely dehydrated pigs, administration of oral fluids may be indicated."
How this level was decided
Level 1 on the second clause -- animals recover acceptably without pathogen-directed treatment. Under Eric's 2026-09-02 rule, C7 scores the value of a treatment that does not exist rather than the industry's willingness to use one, so the question is whether outcomes would meaningfully improve: a self-limiting diarrhoea of three to seven days, supported by rehydration and buffered by maternal antibody, is one where they would not. FLAGGED AS A LEVEL 1 OR 2 JUDGMENT because his rule has a second limb that bites here -- reducing how long an affected pig sheds counts as an outcome worth improving even if no individual pig is saved, and sapovirus is shed for eight to nine days. It is scored level 1 because the shedding is not the problem: the virus is on 88% of farms already, so shortening one pig's shedding changes nothing at herd level. Level 1 held. Supportive fluid therapy is already the appropriate response to a self-limiting diarrhoea, so animals recover acceptably without a pathogen-directed treatment.
C8 Vaccine availability
Availability of effective vaccines or bacterins
Available, or not needed: Effective vaccines are widely available in the US or secured for national outbreak response, or the disease does not clinically or economically justify vaccinating
Basis. No vaccine for porcine sapovirus is mentioned anywhere in chapter 26. 26.3.3.9 gives the control approach in full -- elimination is likely impossible, maternal antibody in colostrum and milk likely limits damage in nursing piglets, and oral rehydration is likely to be successful. 26.3.3.8: "Immune responses, protective immunity induced by porcine sapoviruses, and the role of maternal antibodies HAVE NOT BEEN ASSESSED. However, the finding of an EXTRAINTESTINAL PHASE to the pathogenesis of a porcine sapovirus may mean that other immune strategies might be used for their control."
How this level was decided
Level 1 on the "not needed" clause of the 2026-08-28 rewording. There is no vaccine, so the question is whether the disease would justify one on its own clinical and economic weight, and a self-limiting diarrhoea on nearly every farm does not -- consistent with C5 at level 2 and C7 at level 1 on the same evidence. NOTE THE ONE FINDING THAT COULD CHANGE THIS, which is unusual enough that the chapter draws attention to it: PEC/Cowden produces disease after INTRAVENOUS inoculation as well as oral, and sapovirus particles were found in the bloodstream -- the first viraemia recorded for an enteric calicivirus. The chapter suggests that extraintestinal phase may mean different immune strategies are needed. If sapovirus is later shown to matter more than it appears to, this cell and C5 move together. Unchanged.
Levels and evidence are generated from data/assignments/porcine_sapovirus.yml; the overview is authored in data/overviews/porcine_sapovirus.md. Do not hand-edit this page — corrections go in data/assignments/CORRECTIONS.yml.
Quoted material marked Basis is from Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, Zhang J, eds. Diseases of Swine, 12th edition. Hoboken: Wiley Blackwell, 2025 — except where another source is named in the quotation itself.